Prediction of in vivo drug release behavior of controlled-release multiple-unit dosage forms in dogs using a flow-through type dissolution test method

International Journal of Pharmaceutics

Volumn 258, Issue 1-2, 2003, Pages 31-43

  Ikegami, Kengo ^a   Tagawa, Kozo ^a   Kobayashi, Masao ^a   Osawa, Takashi ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Controlled release; Flow through method; In vitro in vivo correlation; Non sink condition; Theophylline

Indexed keywords

PARACETAMOL; PHENYLPROPANOLAMINE; THEOPHYLLINE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISSOLUTION; DOG; DRUG SOLUBILITY; FLOW THROUGH TYPE DISSOLUTION TEST; GASTROINTESTINAL TRACT; MALE; MULTIPLE DRUG DOSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL;

EID: 0037500844     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00160-1     Document Type: Article

References (21)

1. Butler W.C.G., Bateman S.R. A flow-through dissolution method for a two component drug formulation where the actives have markedly differing solubility properties. Int. J. Pharm. 173:1998;211-219.
2. Davis S.S., Hardy J.G., Fara J.W. Transit of pharmaceutical dosage forms through the small intestine. Gut. 27:1986;886-892.
3. Dietrich R., Brause R., Benedict G., Steinijans V.W. Feasibility of in-vitro/in-vivo correlation in the case of a new sustained-release theophylline pellet formulation. Arzneim.-Forsch./Drug Res. 38:1988;1229-1237.
4. Dressman J.B., Fleisher D. Mixing-tank model for predicting dissolution rate control of oral absorption. J. Pharm. Sci. 75:1986;109-116.
5. Gjellan K., Magnusson A.B., Ahlgren R., Callmer K., Christensen D.F., Espmarker U., Jacobsen L., Jarring K., Lundin G. A collaborative study of the in vitro dissolution of acetylsalicylic acid gastro-resistant capsules comparing the flow-through cell method with the USP paddle method. Int. J. Pharm. 151:1997;81-90.
6. Hussein Z., Friedman M. Release and absorption characteristics of novel theophylline sustained-release formulations - in vitro - in vivo correlation. Pharm. Res. 7:1990;1167-1171.
7. Ishibashi T., Ikegami K., Kubo H., Kobayashi M., Mizobe M., Yoshino H. Evaluation of colonic absorbability of drugs in dogs using a novel colon-targeted delivery capsule (CTDC). J. Control. Rel. 59:1999;361-376.
8. Katori N., Aoyagi N., Terao T. Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation. Pharm. Res. 12:1995;237-243.
9. Mizuta H., Kawazoe Y., Ogawa K. Gastrointestinal absorption of chlorotiazide: evaluation of a method using salicylazosulfapyridine and acetaminophen as the marker compounds for determination of the gastrointestinal transit time in the dog. Chem. Pharm. Bull. 38:1990;2810-2813.
10. Müller H., Langenbucher F. In vitro and in vivo dissolution of some sustained release tablets of theophylline. Pharm. Ind. 44:1982;1065-1071.
11. Narisawa S., Yoshino H., Hirakawa Y., Noda K. Porosity-controlled ethylcellulose film coating. Part III. Application of porous ethylcellulose film coating to capsule-type controlled release preparation of theopylline. Chem. Pharm. Bull. 42:1994;1485-1490.
12. Narisawa S., Nagata M., Ito T., Yoshino H., Hirakawa Y., Noda K. Drug release behavior in gastrointestinal tract of beagle dogs from multiple unit type rate-controlled or time-controlled release preparations coated with insoluble polymer-based film. J. Control. Rel. 33:1995;253-260.
13. Nicklasson M., Graffner C., Nilsson M.I. Assessment of in vivo drug dissolution by means of numerical deconvolution considering gastrointestinal availability. Int. J. Pharm. 40:1987;165-171.
14. Ogata H., Aoyagi N., Kaniwa N., Shibazaki T., Ejima A., Takasugi N., Mafune E., Hayashi T., Suwa K. Bioavailability of nalidixic acid from uncoated tablets in humans. Part I: correlation with the dissolution rates of the tablets. Int. J. Clin. Pharmacol. Ther. Toxicol. 22:1984;175-183.
15. Shammem M., Katori N., Aoyagi N., Kojima S. Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans. Pharm. Res. 12:1995;1049-1054.
16. Talukdar M.M., Plaizier-Vercammen J.A. Flow-through method is advantageous for dissolution experiment of small dosage forms. Pharmazie. 47:1992;458-459.
17. Uchida T., Kawata M., Goto S. In vivo evaluation of ethyl cellulose microcapsules containing ampicillin using rabbits, beagle dogs and humans. J. Pharmacobio-Dyn. 9:1986;631-637.
18. Wagner J.G., Nelson E. Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single doses of drug. J. Pharm. Sci. 53:1964;1392-1403.
19. Yahata, T., Murata, K., Mizobe, M., Noda, K., 1992. Evaluation of drug absorption from colon by balloon tube method, Abstracts 4, In: Proceedings of the 112th Annual Meeting, Pharmaceutical Society of Japan, Fukuoka, March, pp. 60.
20. Yamahara H., Ikegami K., Kubo H., Osawa T., Murata K., Kobayashi M., Noda K. Effect of release rate on bioavailability of controlled-release multiple unit dosage forms. Yakuzaigaku. 55:1995;99-107.
21. Zhang G.H., Vadino W.A., Yang T.T., Cho W.P., Chaudry I.A. Evaluation of the flow-through cell dissolution apparatus: effects of flow rate, glass beads and tablet position on drug release from different type of tablets. Drug Dev. Ind. Pharm. 20:1994;2063-2078.